OBESITY AND ITS RELATIONSHIP WITH CANCER: PART IV Endometrial, Ovarian, Pancreatic, Prostate, Renal and Thyroid Cancers Meningioma and Multiple Myeloma
Article Sidebar
Main Article Content
Abstract
Part I thru III discussed obesity, its general relationship with cancer and its specific impact on six cancers, namely those involving the breast, colorectal tissues, esophagus, stomach. gall bladder, and liver. This part (Part IV) deals with obesity and its relationship with cancers of the endometrium, ovary, pancreas, prostate, kidneys, thyroid, and lung. Meningioma and multiple myeloma are also discussed.
Downloads
Metrics
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Allott E.H., Masko E.M., Freedland S.J. Obesity and prostate cancer: Weighing the evidence. Eur. Urol. 2013;63:800–809. doi: 10.1016/j.eururo.2012.11.013.
Al-Rashed M, Foshay K, Abedalthagafi M. Recent advances in meningioma immunogenetics. Front Oncol. (2019) 9:1472. 10.3389/fonc.2019.01472.
Barcellini A, Roccio M, Laliscia C, et al. Endometrial Cancer: When Upfront Surgery Is Not an Option. Oncology. 2021;99(2):65-71. doi: 10.1159/000510690.
Bardou M, Barkun AN, Martel M. Obesity and colorectal cancer. Gut. 2013;62:933–947. doi: 10.1136/gutjnl-2013-304701.
Bausch D, Keck T. Minimally Invasive Surgery of Pancreatic Cancer: Feasibility and Rationale. Visc Med. 2018 Dec;34(6):440-443.-
Berger N.A. Obesity and cancer pathogenesis. Ann. N. Y. Acad. Sci. 2014;1311:57–76. doi: 10.1111/nyas.12416.
Birmann BM, Giovannucci EL, Rosner BA, et al.Regular aspirin use and risk of multiple myeloma: A prospective analysis in the health professionals follow-up study and nurses' health study. Cancer Prev Res (Phila). 2014;7(1):33–41.
Brandon E.L., Gu J.W., Cantwell L., He Z., Wallace G., Hall J.E. Obesity promotes melanoma tumor growth: Role of leptin. Cancer Biol. Ther. 2009;8:1871–1879. doi: 10.4161/cbt.8.19.9650.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi: 10.3322/caac.21492.
Cabanillas M.E., McFadden D.G., Durante C. Thyroid cancer. Lancet. 2016;388:2783–2795. doi: 10.1016/S0140-6736(16)30172-6.
.Calle EE, Kaaks R. Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004;4:579–91.
Cancer research UK Lung cancer statistics. www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/lung-cancer.
Choi JS, Kim EK, Moon HJ, Kwak JY.. Higher body mass index may be a predictor of extrathyroidal extension in patients with papillary thyroid microcarcinoma. Endocrine. 2015;48(1):264–271.
De Giorgi V., Gori A., Savarese I., et al. Role of BMI and hormone therapy in melanoma risk: A case-control study. J. Cancer Res. Clin. Oncol. 2017;143:1191–1197. doi: 10.1007/s00432-017-2387-5.
Dennis L.K., Lowe J.B., Lynch C.F., Alavanja M.C. Cutaneous melanoma and obesity in the Agricultural Health Study. Ann. Epidemiol. 2008;18:214–221. doi: 10.1016/j.annepidem.2007.09.003.
Eliassen AH , Colditz GA, Rosner B, Willett WC, Hankinson SE. Adult weight change and risk of postmenopausal breast cancer. JAMA. 2006;296(2):193–201
Fang S., Wang Y., Dang Y., Gagel A., Ross M.I., Gershenwald J.E., Cormier J.N., Wargo J., Haydu L.E., Davies M.A., et al. Association between Body Mass Index, C-Reactive Protein Levels, and Melanoma Patient Outcomes. J. Investig. Dermatol. 2017;137:1792–1795. doi: 10.1016/j.jid.2017.04.007.
Ferlay J, Soerjomataram, Ervik M. et al. GLOBOCAN 2012 v1. 0, Cancer incidence and mortality worldwide: IARC CancerBase No. 11. 2013.
Fillon M. Rates of advanced prostate cancer continue to increase. CA Cancer J. Clin. 2020;70:427–429. doi: 10.3322/caac.2164.
Florio AA, Campbell PT, Zhang X, et al. Abdominal and gluteofemoral size and risk of liver cancer: The liver cancer pooling project. Int J Cancer. 2020 Aug 1;147(3):675-685. doi: 10.1002/ijc.32760.
Foong KW, Bolton H. Obesity and ovarian cancer risk: A systematic review. Post Reprod Health. 2017 Dec;23(4):183-198. doi: 10.1177/2053369117709225.
Islam, K. M. A., Khan, M. A. U., Azhar, S., Ahmed, M. R., Khurram, S., Masood, H., & Farooq, L. (2020). Comparison Of In Vitro Activity of Colistin with Ceftolozane/Tazobactam against Multi Drug Resistant Pseudomonas Aeruginosa “A Last Line Treatment against Mdr”. American International Journal of Multidisciplinary Scientific Research, 6(3), 1-7.
Genkinger J.M., Wu K., Wang M., et al. Measures of body fatness and height in early and mid-to-late adulthood and prostate cancer: Risk and mortality in The Pooling Project of Prospective Studies of Diet and Cancer. Ann. Oncol. 2020;31:103–114. doi: 10.1016/j.annonc.2019.09.007.
Global Burden of Disease Cancer Collaboration. The Global Burden of Cancer 2013. JAMA Oncol. 2015;1:505–527. doi: 10.1001/jamaoncol.2015.0735.
Gupta A.,Majumder K.,Arora N.,et al. Premorbid body mass index and mortality in patients with lung cancer: a systematic review and meta-analysis. Lung Cancer. 2016; 102: 49-59.
Haggstrom C, Rapp K, Stocks T, Manjer J, Bjorge T, Ulmer H, et al. Metabolic factors associated with risk of renal cell carcinoma. PLoS ONE. 2013;8(2):e57475 10.1371/journal.pone.0057475.
Hales CM, Carroll MD, Fryar CD, Ogden CL.. Prevalence of obesity among adults and youth: United States. NCHS Data Brief. 2015-2016;2017(288):1–8.
Haugen B.R., Alexander E.K., Bible K.C., et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26:1–133. doi: 10.1089/thy.2015.0020.
Heus C, Smorenburg A, Stoker J, Rutten MJ, Amant FCH, van Lonkhuijzen LRCW. Visceral obesity and muscle mass determined by CT scan and surgical outcome in patients with advanced ovarian cancer. A retrospective cohort study. Gynecol Oncol. 2021 Jan;160(1):187-192. doi: 10.1016/j.ygyno.2020.10.015.) In a meta-analysis.
Hsieh JJ, Purdue MP, Signoretti S, et al. Renal cell carcinoma. Nat Rev Dis Primers. 2017 Mar 09;3:17009.
Huntoon K., Toland A.M.S., Dahiya S. Meningioma: A Review of Clinicopathological and Molecular Aspects. Front. Oncol. 2020;10:579599. doi: 10.3389/fonc.2020.579599.
Ishihara BP, Farah D, Fonseca MCM, Nazario A. The risk of developing breast, ovarian, and endometrial cancer in obese women submitted to bariatric surgery: a meta-analysis. Surg Obes Relat Dis. 2020 Oct;16(10):1596-1602. doi: 10.1016/j.soard.2020.06.008.
Islami F, Goding Sauer A, Miller KD, Siegel RL, Fedewa SA, Jacobs EJ, et al. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA Cancer J Clin. 2018 Jan;68((1)):31–54.
Jiao L, Mitrou PN, Reedy J, Graubard BI, Hollenbeck AR, Schatzkin A, et al. A combined healthy lifestyle score and risk of pancreatic cancer in a large cohort study. Arch Intern Med. 2009;169:764–70.
Jochems S.H.J., Stattin P., Häggström C., Järvholm B., Orho-Melander M., Wood A.M., Stocks T. Height, body mass index and prostate cancer risk and mortality by way of detection and cancer risk category. Int. J. Cancer. 2020;147:3328–3338. doi: 10.1002/ijc.33150.
Jung J.I., Cho H.J., Jung Y.J., et al. High-fat diet-induced obesity increases lymphangiogenesis and lymph node metastasis in the B16F10 melanoma allograft model: Roles of adipocytes and M2-macrophages. Int. J. Cancer. 2015;136:258–270. doi: 10.1002/ijc.28983.
Kim HJ, Kim NK, Choi JH, et al. Associations between body mass index and clinico-pathological characteristics of papillary thyroid cancer. Clin Endocrinol. 2013;78(1):134–140.
Kim WG, Cheng SY.. Mechanisms linking obesity and thyroid cancer development and progression in mouse models. Horm Canc. 2018;9(2):108–116.
Kitahara CM, Pfeiffer RM, Sosa JA, Shiels MS. Impact of Overweight and Obesity on US Papillary Thyroid Cancer Incidence Trends (1995-2015). J Natl Cancer Inst. 2020 Aug 1;112(8):810-817. doi: 10.1093/jnci/djz202.
Kitahara CM, Sosa JA.. The changing incidence of thyroid cancer. Nat Rev Endocrinol. 2016;12(11):646–653),
Kohler BA, Sherman RL, Howlader N, et al. Annual report to the nation on the status of cancer, 1975–2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst. 2011;103:714–736. doi: 10.1093/jnci/djr077.
Kumar SK, Rajkumar SV, Dispenzieri A, et al. Improved survival in multiple myeloma and the impact of novel therapies. Blood. 2008 Mar 1;111(5):2516-20. doi: 10.1182/blood-2007-10-116129.
Kyrgiou M., Kalliala I., Markozannes G., et al. Adiposity and cancer at major anatomical sites: Umbrella review of the literature. BMJ. 2017;356:477. doi: 10.1136/bmj.j477.
Lauby-Secretan B., Scoccianti C., Loomis D., Grosse Y., Bianchini F., Straif K. International Agency for Research on Cancer Handbook Working Group Body Fatness and Cancer--Viewpoint of the IARC Working Group. N. Engl. J. Med. 2016;375:794–798. doi: 10.1056/NEJMsr1606602.
Leonardi GC, Falzone L, Salemi R, Zanghi A, Spandidos DA, McCubrey JA, Candido S. et al. Cutaneous melanoma: From pathogenesis to therapy (Review) Int J Oncol. 2018;52(4):1071–1080. doi: 10.3892/ijo.2018.4287.
Leung C.C.,Lam T.H.,Yew W.W. et al. Lower lung cancer mortality in obesity. Int J Epidemiol. 2011; 40: 174-182.
Lheureux S., Braunstein M., Oza A.M. Epithelial ovarian cancer: Evolution of management in the era of precision medicine. CA Cancer J. Clin. 2019;69:280–304. doi: 10.3322/caac.21559.
Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM.. Trends in thyroid cancer incidence and mortality in the United States, 1974-2013. JAMA. 2017;317(13):1338–1348.
Liu E, Wang X, Yuan J, Gao Y. Association of body mass index with risk of lung cancer Evidence from a middle aged male cohort in shanghai china. Chinese J Clin Oncol 2004; 2: 90–5.
MacInnis R.J., English D.R. Body size and composition and prostate cancer risk: Systematic review and meta-regression analysis. Cancer Causes Control. 2006;17:989–1003. doi: 10.1007/s10552-006-0049-z.
Mahdy H, Casey MJ, Crotzer D. Endometrial Cancer. 2021 Jul 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan-.
Marinac C.R., Birmann B.M., Lee I.-M., et al. Body mass index throughout adulthood, physical activity, and risk of multiple myeloma: A prospective analysis in three large cohorts. Br. J. Cancer. 2018;118:1013–1019. doi: 10.1038/s41416-018-0010-4.
McCullough M L, Patel A V, Patel R. Body mass and endometrial cancer risk by hormone replacement therapy and cancer subtype. doi:10.1158/1055-9965.epi-07-2567. Cancer Epidemiol Biomarkers Prev. 2008;17:73–79.
McGuigan A, Kelly P, Turkington RC, Jones C, Coleman HG, McCain RS. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes. World J Gastroenterol. 2018;24:4846–4861.
Miller A.J., Mihm M.C. Melanoma. N. Engl. J. Med. 2006;355:51–65. doi: 10.1056/NEJMra052166.
Modolell I, Guarner L, Malagelada JR. Vagaries of clinical presentation of pancreatic and biliary tract cancer. Ann Oncol 1999;10 Suppl 4:82-4.
National Cancer Institute Surveillance, Epidemiology, and End Results Program Cancer Stat Facts: Thyroid Cancer. [(accessed on 2 September 2020)]; Available online: https://seer.cancer.gov/statfacts/html/thyro.html.
Nimptsch U., Krautz C., Weber G.F., Mansky T., Grützmann R. Nationwide In-hospital Mortality Following Pancreatic Surgery in Germany is Higher than Anticipated. Ann. Surg. 2016;264:1082–1090. doi: 10.1097/SLA.0000000000001693.
Onstad M A, Schmandt R E, Lu K H. Addressing the Role of Obesity in Endometrial Cancer Risk, Prevention, and Treatment. doi:10.1200/JCO.2016.69.4638. J Clin Oncol. 2016;34:4225–4230.
Ostrom Q.T., Cioffi G., Gittleman H., Patil N., Waite K., Kruchko C., Barnholtz-Sloan J.S. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012–2016. Neuro Oncol. 2019;21:v1–v100. doi: 10.1093/neuonc/noz150.
Pandey V., Vijayakumar M.V., Ajay A.K., Malvi P., Bhat M.K. Diet-induced obesity increases melanoma progression: Involvement of Cav-1 and FASN. Int. J. Cancer. 2012;130:497–508. doi: 10.1002/ijc.26048,
Parkin DM, Boyd L, Walker LC. 16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010. Br J Cancer. 2011 Dec;105((S2 Suppl 2)):S77–81.
Pothiawala S., Qureshi A.A., Li Y., Han J. Obesity and the incidence of skin cancer in US Caucasians. Cancer Causes Control. 2012;23:717–726. doi: 10.1007/s10552-012-9941-x.
Præstegaard C., Kjær S.K., Christensen J., Tjønneland A., Halkjær J., Jensen A. Obesity and risks for malignant melanoma and non-melanoma skin cancer: Results from a large danish prospective cohort study. J. Investig. Dermatol. 2015;135:901–904. doi: 10.1038/jid.2014.438.
Rajkumar SV, Dimopoulos MA, Palumbo A, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15(12):e538-e548.
Rawla P, Sunkara T, Gaduputi V. Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors. World J Oncol. 2019 Feb;10((1)):10–27.
Rivera-Izquierdo M, Pérez de Rojas J, Martínez-Ruiz V, et al. Obesity as a Risk Factor for Prostate Cancer Mortality: A Systematic Review and Dose-Response Meta-Analysis of 280,199 Patients. Cancers (Basel). 2021 Aug 19;13(16):4169. doi: 10.3390/cancers13164169.
Samanic C, Chow WH, Gridley G, Jarvholm B, Fraumeni JF, Jr. Relation of body mass index to cancer risk in 362,552 Swedish men. Cancer Causes Control 2006; 17: 901–9.
Schmid D, Ricci C, Behrens G, Leitzmann MF. Adiposity and risk of thyroid cancer: a systematic review and meta-analysis. Obes Rev. 2015;16(12):1042-1054.
Schwartz AG, Cote ML. Epidemiology of Lung Cancer. Adv Exp Med Biol. 2016;893:21-41. doi: 10.1007/978-3-319-24223-1_2.
SEER*Stat Database: NAACCR Incidence Data - CiNA Analytic File, 1995–2014, for Expanded Races, Custom File With County, ACS Facts and Figures projection Project (which includes data from CDC’s National Program of Cancer Registries (NPCR), CCCR’s Provincial and Territorial Registries, and the NCI’s Surveillance, Epidemiology and End Results (SEER) Registries), certified by the North American Association of Central Cancer Registries (NAACCR) as meeting high-quality incidence data standards for the specified time periods, submitted December 2016.
Seliger C, Meier CR, Becker C, et al. Metabolic syndrome in relation to risk of meningioma. Oncotarget. 2017;8:2284–2292. doi: 10.18632/oncotarget.13667.
Sergentanis T.N., Antoniadis A.G., Gogas H.J., et al. Obesity and risk of malignant melanoma: A meta-analysis of cohort and case-control studies. Eur. J. Cancer. 2013;49:642–657. doi: 10.1016/j.ejca.2012.08.028.
Shao C, Bai LP, Qi ZY, Hui GZ, Wang Z. Overweight, obesity and meningioma risk: a meta-analysis. PLoS One. 2014 Feb 26;9(2):e90167. doi: 10.1371/journal.pone.0090167.
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7–30.
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin 2017;67:7-30.
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34.
Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2020. CA Cancer J. Clin. 2020;70:7–30. doi: 10.3322/caac.21590.
Skowron F., Bérard F., Balme B., Maucort-Boulch D. Role of obesity on the thickness of primary cutaneous melanoma. J. Eur. Acad. Dermatol. Venereol. 2015;29:262–269. doi: 10.1111/jdv.12515.
Soong SJ, Harrison RA, McCarthy WH, Urist MM, Balch CM. Factors affecting survival following local, regional, or distant recurrence from localized melanoma. J Surg Oncol. 1998;67:228–233.
Sung H, Siegel RL, Rosenberg PS, Jemal A. Emerging cancer trends among young adults in the USA: analysis of a population-based cancer registry. Lancet Public Health. 2019 Mar;4((3)):e137–47.
Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2021;71:209–249. doi: 10.3322/caac.21660.
Takahashi H, Cornish AJ, Sud A, et al. Mendelian randomization provides support for obesity as a risk factor for meningioma. Sci Rep. 2019 Jan 22;9(1):309. doi: 10.1038/s41598-018-36186-6.
Tas F. Metastatic behavior in melanoma: timing, pattern, survival, and influencing factors.. J Oncol. 2012;2012:647684.
Téoule P., Bartel F., Birgin E., Rückert F., Wilhelm T.J. The Clavien-Dindo Classification in Pancreatic Surgery: A Clinical and Economic Validation. J. Invest. Surg. 2019;32:314–320. doi: 10.1080/08941939.2017.1420837.
Thordardottir M, Lindqvist EK, Lund SH, et al. Obesity and risk of monoclonal gammopathy of undetermined significance and progression to multiple myeloma: a population-based study. Blood Adv. 2017;1(24):2186-2192. Published 2017 Nov 1. doi:10.1182/bloodadvances.2017007609.
Torre L.A., Trabert B., DeSantis C.E., Ovarian cancer statistics, 2018. [(accessed on 29 May 2018)];CA Cancer J. Clin. 2018 68:284–296. Available online: https://pubmed.ncbi.nlm.nih.gov/29809280.
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA: a cancer journal for clinicians. 2015;65(2):87–108. 10.3322/caac.21262.
Tresallet C, Seman M, Tissier F, et al. The incidence of papillary thyroid carcinoma and outcomes in operative patients according to their body mass indices. Surgery. 2014;156(5):1145–1152.
Webb P.M., Jordan S.J. Epidemiology of epithelial ovarian cancer. Best Pract. Res. Clin. Obstet. Gynaecol. 2017;41:3–14. doi: 10.1016/j.bpobgyn.2016.08.006.
Weiss BM, Abadie J, Verma P, Howard RS, Kuehl WM. A monoclonal gammopathy precedes multiple myeloma in most patients. Blood. 2009;113(22):5418-5422.
Wiedmann M, et al. Body mass index and the risk of meningioma, glioma and schwannoma in a large prospective cohort study (The HUNT Study) Br J Cancer. 2013;109:289–294. doi: 10.1038/bjc.2013.304.
Wiedmann, M. K. H. et al. Overweight, obesity and height as risk factors for meningioma, glioma, pituitary adenoma and nerve sheath tumor: a large population-based prospective cohort study. Acta Oncol, 1–8, 10.1080/0284186X.2017.1330554 (2017).
Williams T.K., Rosato E.L., Kennedy E.P., et al. Impact of obesity on perioperative morbidity and mortality after pancreaticoduodenectomy. J. Am. Coll. Surg. 2009;208:210–217. doi: 10.1016/j.jamcollsurg.2008.10.019.
Wilson KM, Cho E. Obesity and Kidney Cancer. Recent Results Cancer Res. 2016;208:81-93. doi: 10.1007/978-3-319-42542-9_5.
Wise M R, Jordan V, Lagas A. Obesity and endometrial hyperplasia and cancer in premenopausal women: A systematic review. doi:10.1016/j.ajog.2016.01.175 Am J Obstet Gynecol. 2016;214:6890–6.89E19.
World Cancer Research Fund International/American Institute for Cancer Research. Continuous Update Project Report: Diet, Nutrition, Physical Activity and Kidney Cancer. 2015. https://www.wcrf.org/sites/default/files/Kidney-cancer-report.pdf.
World Cancer Research Fund/American Institute for Cancer Research Diet, Nutrition, Physical Activity and Cancer: a Global Perspective. The Third Expert Report. Available from www.wcrf.org/dietandcancer.
www.cancer.net/types/lung-cancer-non-small-cell/statistics - accessed October 10, 2021.
www.myelomacrowd.org/obesity-and-mgus-progression.
www.pancan.org/facing-pancreatic-cancer/about-pancreatic-cancer/types-of-pancreatic-cancer/.
Yang R.,Cheung M.C., Pedroso F.E., et al. Obesity and weight loss at presentation of lung cancer are associated with opposite effects on survival. J Surg Res. 2011; 170: e75-e83.
Yang TO, et al. Body size in early life and risk of lymphoid malignancies and histological subtypes in adulthood. Int J Cancer. 2016;139:42–49. doi: 10.1002/ijc.30044.
Yu D, Zheng W, Johansson M, Lan Q, Park Y, et al. Overall and Central Obesity and Risk of Lung Cancer: A Pooled Analysis. J Natl Cancer Inst. 2018 Aug 1;110(8):831-842.
Zhang D., Chen J., Wang J., et al. Body Mass Index and Risk of Brain Tumors: A Systematic Review and Dose-Response Meta-Analysis. Eur. J. Clin. Nutr. 2016;70:757–765. doi: 10.1038/ejcn.2016.4.
Zhang Y, Liu H, Yang S, Zhang J, Qian L, Chen X. Overweight, obesity and endometrial cancer risk: results from a systematic review and meta-analysis. Int J Biol Markers. 2014;29:e21–e29.